Experian experiences slight slowdown in first quarter

The credit checking giant reported revenues up 4% in the three months to 30 June, compared to the 6% reported growth in the past year

The fourth quarter of the previous year had been particularly strong

Experian PLC (LON:EXPN) reported a slight softening in growth at the start of its new financial year, though there were silver linings in a recovery in the UK consumer arm and in the Brazilian business.  

The credit checking giant reported revenues up 4% in the three months to 30 June, or up 7% at constant exchange rates, with organic growth up 6%.

READ: Credit Suisse doesn’t see the value in Experian after recent share price surge

This was slower that the 6% reported growth in the past year, when organic revenue had risen 9% after a fourth quarter rise of 10%.

“We are excited about our prospects and for the year ahead our guidance is unchanged,” said chief executive Brian Cassin.

In the UK & Ireland, total and organic revenue growth was flat as the consumer arm returned to growth in the quarter but was offset by a 1% decline in B2B. The decisioning segment saw a 13% decline compared to a strong prior-year quarter.

North America delivered 8% organic growth, with consumer services up 9% as in the prior quarter and B2B at 8%.

Latin America’s organic revenues were up 9%, with Brazil said to be coming back “strongly, with encouraging performances across the business” and further growth in Spanish Latin America, especially in Colombia.

Currency volatility had around a 2% impact on organic revenues at this stage, feeding through to a 1% hit to underlying profit for the full year.

Broker Shore Capital said: "We expect Experian to continue to deliver good organic growth with strong cash generation reflecting stable margin performance – leveraging growing demand for its data capability across geographic regions and vertical segments."

Experian shares, which hit an all-time high of almost 2,500p in recent weeks, were down 2% to 2,370p on Tuesday. 

Quick facts: Experian

Price: 2971 GBX

Market: LSE
Market Cap: £27.24 billion

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


GinsGlobal Managing Director sees Healthcare and Healthcare innovation as...

HANetf and GinsGlobal Index Funds' Managing Director Anthony Ginsberg joined Steve Darling from Proactive to share details about the success of their Healthcare Innovations ETF. Ginsberg discusses how COVID-19 had made a direct impact on that fund, especially in the telemedicine...

15 hours, 3 minutes ago

2 min read